Manulife (Manufacturers Life Insurance)
EGRX

Manulife (Manufacturers Life Insurance)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,789
Closed -$237K – 3176
2022
Q1 		$237K Sell
4,789
-1,252
-21% -$60.1K ﹤0.01% 2658
2021
Q4 		$308 Sell
6,041
-109
-2% -$5.65K ﹤0.01% 2591
2021
Q3 		$343K Sell
6,150
-1,085
-15% -$53.4K ﹤0.01% 2568
2021
Q2 		$310K Buy
7,235
+866
+14% +$35.7K ﹤0.01% 2791
2021
Q1 		$266K Sell
6,369
-250
-4% -$11.6K ﹤0.01% 2694
2020
Q4 		$308K Sell
6,619
-34
-0.5% -$1.59K ﹤0.01% 2503
2020
Q3 		$283K Hold
6,653
– – ﹤0.01% 2335
2020
Q2 		$319K Buy
6,653
+704
+12% +$35.1K ﹤0.01% 2212
2020
Q1 		$274K Buy
5,949
+374
+7% +$18.8K ﹤0.01% 2150
2019
Q4 		$335K Sell
5,575
-204
-4% -$12.2K ﹤0.01% 2271
2019
Q3 		$326K Sell
5,779
-323
-5% -$18.2K ﹤0.01% 2276
2019
Q2 		$340K Buy
6,102
+2,017
+49% +$105K ﹤0.01% 2288
2019
Q1 		$206K Buy
+4,085
New +$182K ﹤0.01% 2420
2018
Q4 		– Sell
-7,102
Closed -$492K – 2862
2018
Q3 		$492K Sell
7,102
-835
-11% -$63.3K ﹤0.01% 2310
2018
Q2 		$601K Buy
7,937
+1,654
+26% +$104K ﹤0.01% 2234
2018
Q1 		$332K Sell
6,283
-181
-3% -$10.5K ﹤0.01% 2641
2017
Q4 		$345K Sell
6,464
-75
-1% -$4.17K ﹤0.01% 2585
2017
Q3 		$390K Sell
6,539
-14
-0.2% -$847 ﹤0.01% 2450
2017
Q2 		$517K Sell
6,553
-524
-7% -$42.9K ﹤0.01% 2261
2017
Q1 		$587K Buy
7,077
+848
+14% +$63K ﹤0.01% 2071
2016
Q4 		$494K Sell
6,229
-185
-3% -$13.4K ﹤0.01% 2100
2016
Q3 		$449K Sell
6,414
-110
-2% -$6.09K ﹤0.01% 2152
2016
Q2 		$253K Buy
6,524
+675
+12% +$28.1K ﹤0.01% 2536
2016
Q1 		$228K Buy
5,849
+3
+0.1% +$190 ﹤0.01% 2512
2015
Q4 		$518 Buy
5,846
+57
+1% +$4.5K ﹤0.01% 2002
2015
Q3 		$429 Buy
5,789
+110
+2% +$9.15K ﹤0.01% 2096
2015
Q2 		$460 Buy
+5,679
New +$370K ﹤0.01% 2182

Other funds holding EGRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s EGRX Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2022, closing a stake of 4,789 shares — an estimated $237K sold.

Manulife (Manufacturers Life Insurance) first reported a position in EGRX in Q2 2015 and held it in 27 quarters. The position peaked at $601K in Q2 2018. 163 funds tracked by Wall St. Rank hold EGRX as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 4,789 Eagle Pharmaceuticals, Inc. shares in Q2 2022, an estimated $237K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 27 quarters.
  • Manulife (Manufacturers Life Insurance)'s Eagle Pharmaceuticals, Inc. position peaked at $601K in Q2 2018.
  • 163 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.